4 articles tagged with "biotech"
Cambrian's latest drug, Encanta, seeks to replicate the health benefits of exercise, potentially enhancing longevity and healthspan according to early research.
Recent reports highlight significant improvements in pancreatic cancer survival rates and ongoing developments in lung cancer drugs, alongside the rapid growth of China's biotech industry.
Vericel's recent revenue surge of 20% has piqued investor interest, highlighted by a significant $63 million increase in investment from a notable biotech investor.
The recent departure of significant FDA officials has sparked worries among biotech executives about the future of rare disease drug development, emphasizing the need for regulatory stability.